Antecedentes. La enfermedad pulmonar obstructiva crónica es una patología común caracterizada por una limitación crónica, progresiva e irreversible al flujo aéreo, afecta millones de personas en el mundo. Objetivo.
Ariel Pérez-Monroy +2 more
doaj
[Unresolved questions about the treatment of COVID-19 with corticosteroids]. [PDF]
Corral-Gudino L +2 more
europepmc +1 more source
[Carmustine Pulmonary Toxicity: A Diagnosis to Bear in Mind Even in Times of COVID]. [PDF]
Gómez-Carballo C, Pedrero S.
europepmc +1 more source
[Isolation of Turicella otitidis in ear infection]. [PDF]
Mendez-Legaza JM +4 more
europepmc +1 more source
Primary adrenal insufficiency and systemic tuberculosis in a 10-year-old boy: case report. [PDF]
Schult-Montoya S, Lindo-Pérez FR.
europepmc +1 more source
[Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina]. [PDF]
Marín GH +7 more
europepmc +1 more source
[Treatment protocol for COVID-19 in patients with and without an indication for hospital admission]. [PDF]
García GH, Allende JMB, Moreno FGSYJS.
europepmc +1 more source
Delayed infant development: content analysis of a nursing diagnosis proposal. [PDF]
Aquino MDST +6 more
europepmc +1 more source
Informe técnico hidrocortisona 0.01 crema
La Dirección General de Medicamentos, Insumos y Drogas, considera que la adquisición efectuada de Hidrocortisona al 1% crema, autorizada por el Comité Farmacológico de la DISA I CALLAO se encuentra justificada para la indicación solicitada, por inexistencia en el mercado nacional de la hidrocortisona 0.5% crema.
openaire +1 more source
Hydrocortisone Aceponate for Chronic Otitis: Long-Term Efficacy. [PDF]
Lorente-Méndez C, Alonso-Miguel D.
europepmc +1 more source

